IRB fees are required for the review of new protocols and annual continuing review applications for clinical studies of drugs and devices sponsored by pharmaceutical firms and other for-profit entities. Fees will not be charged for Federal, non-profit foundations, or investigator-funded studies.
Contract Size |
IRB Fee |
>$50,000 |
$2,000 |
< $50,000 |
$1,200 |
Continuing Contracts |
$300 |
< $5,000 |
Discuss possibility of waiver with CPHS |
* Fees are subject to change.
Payment of IRB fees are invoiced to PIs when protocols are scheduled for CPHS review, and all fees are the responsibility of the PI. PIs should include IRB fees with associated indirect costs, if applicable, as a line item in the budget of the formal contract as an upfront and non-refundable item.
|
